{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:04:21Z","timestamp":1781013861650,"version":"3.54.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> This study aimed to identify the clinical features of Kawasaki disease shock syndrome (KDSS) in children.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The case-control studies of KDSS and KD children up until April 30, 2021 were searched in multiple databases. The qualified research were retrieved by manually reviewing the references. Review Manager 5.3 software was used for statistical analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results showed that there was no significant difference in the incidence of male and female in children with KDSS. Children with KDSS compared with non-shocked KD, there were significant difference in age, duration of fever, white blood cell (WBC) count, percentage of neutrophils (NEUT%), platelet count (PLT), c-reactive protein level (CRP), alanine transaminase concentration (ALT), aspartate transaminase concentration (AST), albumin concentration (ALB), sodium concentration (Na), ejection fraction, and length of hospitalization as well as the incidence of coronary artery dilation, coronary artery aneurysm, left ventricular dysfunction, mitral regurgitation, pericardial effusion, initial diagnosis of KD, intravenous immunoglobulin (IVIG) resistance and receiving second dose of IVIG, vasoactive drugs, hormones, and albumin. In contrast, there was no difference in the hemoglobin concentration, erythrocyte sedimentation rate, and the incidence of conjunctival injection, oropharyngeal change, polymorphous rash, extremity change, and incomplete KD.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Current evidence suggested that the children with KDSS had more severe indicators of inflammation and more cardiac abnormalities. These patients were resistant to immunoglobulin treatment and required extra anti-inflammatory treatment.<\/jats:p><jats:p><jats:bold>Systematic Review Registration:<\/jats:bold> PROSPERO registration number CRD42021241207.<\/jats:p>","DOI":"10.3389\/fcvm.2021.736352","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T05:50:14Z","timestamp":1632203414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Zhimin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengye","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1542\/peds.2008-1871","article-title":"Recognition of a Kawasaki disease shock syndrome","volume":"123","author":"Kanegaye","year":"2009","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/INF.0b013e31829efae6","article-title":"Population-based study of Kawasaki disease shock syndrome in Taiwan","volume":"32","author":"Lin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/INF.0000000000002982","article-title":"kawasaki disease and kawasaki disease shock syndrome hospitalization rates in the United States, 2006-2018","volume":"40","author":"Maddox","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"B9","unstructured":"ShiJ\n            LuoD\n            WanX\n            LiuY\n            LiuJ\n            BianZ\n          Detecting the Skewness of Data From the Sample Size and the Five-Number Summary [Preprint]"},{"key":"B10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00431-012-1879-1","article-title":"Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children","volume":"172","author":"G\u00e1mez-Gonz\u00e1lez","year":"2013","journal-title":"Eur J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmii.2013.06.005","article-title":"Clinical manifestations of Kawasaki disease shock syndrome: a case-control study","volume":"48","author":"Chen","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10067-016-3316-8","article-title":"Describing Kawasaki shock syndrome: results from a retrospective study and literature review","volume":"36","author":"Taddio","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jpids\/piw081","article-title":"Hyponatremia is a feature of kawasaki disease shock syndrome: a case-control study","volume":"6","author":"Schuster","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3760\/cma.j.issn.1673-4912.2017.12.012","article-title":"Clinical manifestations of 16 cases with Kawasaki disease shock syndrome. Chinese Pediatric Emergency","volume":"24","author":"Qi","year":"2017","journal-title":"Medicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/0009922817729483","article-title":"Clinical Manifestations of Kawasaki Disease Shock Syndrome","volume":"57","author":"Ma","year":"2018","journal-title":"Clin Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","article-title":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-\u03b3 as biomarkers for early recognition","volume":"17","author":"Li","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3969\/j.issn.1000-3606.2019.04.002","article-title":"Clinical characteristics of Kawasaki disease shock syndrome","volume":"37","author":"Zhao","year":"2019","journal-title":"J Clin Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3969\/j.issn.1005-8982.2020.09.016","article-title":"A comparative analysis of the clinical characteristics of Kawasaki shock syndrome and Kawasaki disease","volume":"30","author":"Du","year":"2020","journal-title":"China J Modern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3969\/j.issn.1671-3141.2021.14.056","article-title":"Clinical characteristics and serum cytokine levels in patients with Kawasaki disease shock syndrome","volume":"21","author":"Su","year":"2021","journal-title":"World Latest Med Inform"},{"key":"B20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12887-020-02488-w","article-title":"Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study","volume":"21","author":"Park","year":"2021","journal-title":"BMC Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.13407\/j.cnki.jpp.1672-108X.2021.04.006","article-title":"Clinical analysis of kawasaki disease shock syndrome in 17 children","volume":"27","author":"Li","year":"2021","journal-title":"J Pediatr Pharm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S1047951118002056","article-title":"Association between left ventricular ejection fraction and Kawasaki disease shock syndrome","volume":"29","author":"Qiu","year":"2019","journal-title":"Cardiol Young"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/ped.13614","article-title":"Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease","volume":"60","author":"Gamez-Gonzalez","year":"2018","journal-title":"Pediatr Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/08880010390243004","article-title":"Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms","volume":"20","author":"Nofech-Mozes","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1253\/circj.CJ-16-0541","article-title":"Transcriptional analysis of intravenous immunoglobulin resistance in kawasaki disease using an induced pluripotent stem cell disease model","volume":"81","author":"Ikeda","year":"2016","journal-title":"Circ J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5863\/1551-6776-20.3.163","article-title":"Overview of pharmacological treatment options for pediatric patients with refractory kawasaki disease","volume":"20","author":"Saneeymehri","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"B28","first-page":"829","article-title":"Continuous hemofiltration plus plasma exchange in patient with kawasaki disease shock syndrome: a case report and literature review","volume":"49","author":"Miao","year":"2019","journal-title":"Ann Clin Lab Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.4103\/0366-6999.219151","article-title":"Clinical analysis of kawasaki disease shock syndrome","volume":"130","author":"Zhang","year":"2017","journal-title":"Chin Med J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fped.2019.00221","article-title":"Extracorporeal membrane oxygenation support for cardiac dysfunction due to Kawasaki disease shock syndrome","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3877\/cma.j.issn.1674-6880.2015.04.005","article-title":"Clinical manifestations and risk factors of Kawasaki disease shock syndrome","volume":"4","author":"Qiu","year":"2015","journal-title":"Chin J Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3760\/cma.j.issn.2095-428X.2018.09.006","article-title":"Clinical characteristics of Kawasaki disease shock syndrome in children and its related factors","volume":"33","author":"Shan","year":"2018","journal-title":"J Appl Clin Pediatr"},{"key":"B33","first-page":"2128","article-title":"The application value of early identification of Kawasaki disease shock syndrome by detecting the level of interleukin 6 combined with interleukin 10 in peripheral blood","volume":"29","author":"Shen","year":"2019","journal-title":"Chin J Health Lab Technol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.736352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T05:50:25Z","timestamp":1632203425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.736352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2021.736352"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.736352","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"article-number":"736352"}}